Effect of Cold Plasma-Treated Solution on the Ability of Doxorubicin and Medroxyprogesterone Acetate to Suppress Breast Cancer Cell Proliferation
Authors:
- 1 April 2026
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Chemistry Journal
- Vol. 60 (1) , 20-24
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cold atmospheric plasma-activated liquid inhibits peritoneal metastasis in drug-resistant ovarian cancer by targeting the epithelial-mesenchymal transitionClinical & Experimental Metastasis, 2025
- Targeting autophagy in doxorubicin-induced cardiotoxicity: A comprehensive review of scientific landscapes and therapeutic innovationsAgeing Research Reviews, 2025
- Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration dataThe Breast, 2024
- Antitumor progestins activity: Cytostatic effect and immune responseSteroids, 2024
- Plasma-activated medium inhibits cancer stem cell-like properties and exhibits a synergistic effect in combination with cisplatin in ovarian cancerFree Radical Biology and Medicine, 2022
- Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cellsCancer Chemotherapy and Pharmacology, 2022
- Study of Characteristics of the Cold Atmospheric Plasma Source Based on a Piezo TransformerRussian Physics Journal, 2020
- Roles of intracellular and extracellular ROS formation in apoptosis induced by cold atmospheric helium plasma and X-irradiation in the presence of sulfasalazineFree Radical Biology and Medicine, 2018
- Tetrazolium salts and formazan products in Cell Biology: Viability assessment, fluorescence imaging, and labeling perspectivesActa Histochemica, 2018
- Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancerJournal of Cancer Research and Clinical Oncology, 1988